Teresa S. Latham, DrPH

Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations. Power-Hays, A; Mcelhinney, KE; Williams, TN; Mochamah, G; Olupot-Olupot, P; Paasi, G; Reid, ME; Rankine-Mullings, AE; Opoka, RO; John, CC; Stuber, SE; Latham, TS; Vinks, AA; Ware, RE. Blood advances. 2026; 10(2):418-427.

Development of disease-specific growth curves from Kenyan children with sickle cell anemia. Tomlinson, GA; Backeljauw, P; Mochamah, G; Smart, LR; Latham, TS; Ware, RE; Williams, TN. Blood Global Hematology. 2025; 1(3):100031.

Full assessment of clinical transfusion support (FACTS): A prospective Study to determine the burden of sickle cell anemia on pediatric blood transfusion use in a malaria-endemic region in Africa. Power-Hays, A; Namazzi, R; Mcelhinney, K; Kincaid, A; Kato, C; Aliwuya, S; Opoka, R; Conroy, A; John, C; Hume, HA; Stuber, S; Latham, T; Ware, R. Blood. 2025; 146(Supplement 1):300-300.

Health status of Ugandan children born with sickle cell anemia and congenital HIV identified through newborn screening. Latham, T; Kiyaga, C; Hernandez, A; Nakafeero, M; Kadde, N; Khainza, P; Stuber, S; Ndeezi, G; Aceng, J; Ware, R. Blood. 2025; 146(Supplement 1):2668.

Measles vaccine-induced sero-protection among children with sickle cell anemia. Power-Hays, A; Kincaid, A; Mcelhinney, K; Latham, T; Quinn, C; Frenck, R; Ware, R. Blood. 2025; 146(Supplement 1):1168.

Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial. Nieves, RM; Latham, T; Marte, N; Berges, M; Sánchez, LM; Urcuyo, G; Florencio, C; Gonzalez, C; Del Villar, P; Chen, S; Schultz, WH; Lane, AC; Mena, R; Ware, RE. Blood advances. 2025; 9(8):1791-1800.

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial. Power-Hays, A; Namazzi, R; Kato, C; Mcelhinney, KE; Conroy, AL; Hume, H; John, C; O'hara, SM; Stuber, SE; Lane, A; Latham, TS; Opoka, RO; Ware, RE. Acta Haematologica. 2025; 148(2):208-219.

Assessing educational needs of sickle cell anemia healthcare providers in sub-Saharan Africa and the Caribbean. Latham, TS; Ware, RE; Shook, LM. Frontiers in Public Health. 2025; 13:1693285.

Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa. Segbefia, CI; Smart, LR; Stuber, SE; Amissah-Arthur, KN; Dzefi-Tettey, K; Ekpale, P; Mensah, E; Lane, AC; Ghunney, W; Tagoe, LG; Oteng, A; Amoako, E; Latham, TS; Dei-Adomakoh, YA; Ware, RE. British Journal of Haematology. 2024; 205(6):2470-2480.

A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy. Sadaf, A; Dong, M; Pfeiffer, A; Korpik, J; Kalfa, TA; Latham, T; Vinks, AA; Ware, RE; Quinn, CT. British Journal of Haematology. 2024; 205(3):1147-1158.